Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Onkos Surgical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Onkos Surgical

Onkos Surgical

Series B

Onkos Surgical: A private firm innovating surgical oncology with cutting-edge technology.

HQ
Parsippany-Troy Hills, NJ, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to advance the field of surgical oncology, Onkos Surgical is a privately-held company dedicated to providing innovative technology and solutions for surgical oncologists. The company focuses on developing specialized implants and instruments tailored for tumor and revision orthopedic surgeries, including patient-specific 3D printed pelvic reconstruction systems. Onkos Surgical aims to improve patient outcomes by addressing the unique challenges faced in musculoskeletal oncology.

Notable achievements include receiving the first FDA De Novo approval for an antibacterial coating on tumor and revision orthopedic implants, as well as FDA clearance for their 3D printed, patient-specific pelvic reconstruction system. The company has also expanded its capabilities in pediatric musculoskeletal oncology and established a new Manufacturing and Innovation Center. These milestones underscore Onkos Surgical's impact on enhancing surgical oncology practices and improving patient care.

Onkos Surgical - Similar Companies

CairnSurgical logo

CairnSurgical

OnPoint Surgical logo

OnPoint Surgical

OsseoPrint 3D logo

OsseoPrint 3D

osseoprint3d.com

RevOrtho logo

RevOrtho

revortho.com

AlgoSurg Inc logo

AlgoSurg Inc

algosurg.com

Current Surgical logo

Current Surgical

Edge Surgical logo

Edge Surgical

edgesurgical.com

Guided Surgery Solutions logo

Guided Surgery Solutions

Think Surgical logo

Think Surgical

thinksurgical.com

Buck Surgical logo

Buck Surgical

bucksurgical.com

Emet Surgical logo

Emet Surgical

emetsurgical.com

Nascent Surgical logo

Nascent Surgical

Simparo Surgical logo

Simparo Surgical

Prescient Surgical logo

Prescient Surgical

3D Operations logo

3D Operations

3dops.co

Onkos Surgical - Quick Facts

Who are Onkos Surgical's competitors?

Companies similar to Onkos Surgical include CairnSurgical, OnPoint Surgical, OsseoPrint 3D and RevOrtho.

When was Onkos Surgical founded?

Onkos Surgical was founded in 2015.

Where is Onkos Surgical's headquarters located?

Onkos Surgical's headquarters is located in Parsippany-Troy Hills, NJ, US.

When was Onkos Surgical's last funding round?

Onkos Surgical's most recent funding round was for $26.5M (USD) in June 2022.

How much has Onkos Surgical raised to-date?

As of Jun 16, 2022, Onkos Surgical has raised a total of $85.2M (USD).

How many employees does Onkos Surgical have?

Onkos Surgical has 89 employees as of Feb 5, 2024.

Onkos Surgical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • 3d Printing
Main Product
  • Surgical Implants
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified